We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+0.26%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$30.7B
AUM Growth
+$988M
Cap. Flow
+$1.01B
Cap. Flow %
3.28%
Top 10 Hldgs %
54.65%
Holding
2,179
New
164
Increased
802
Reduced
752
Closed
188

Sector Composition

Rank Sector Weight
1 Financials 4.77%
2 Technology 4.11%
3 Healthcare 1.86%
4 Consumer Discretionary 1.76%
5 Industrials 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTBL
1826
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$30K ﹤0.01%
629
NAK
1827
Northern Dynasty Minerals
NAK
$885M
$29K ﹤0.01%
49,475
-68,200
-58% -$43.8K
SND icon
1828
Smart Sand
SND
$200M
$29K ﹤0.01%
+10,100
New +$25.2K
ECT
1829
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$29K ﹤0.01%
23,997
-147
-0.6% -$216
SIFY
1830
Sify Technologies
SIFY
$1.02B
$28K ﹤0.01%
3,335
ASRT
1831
DELISTED
Assertio
ASRT
$27K ﹤0.01%
+356
New +$46.3K
CLDX icon
1832
Celldex Therapeutics
CLDX
$2.77B
$27K ﹤0.01%
12,566
+53
+0.4% +$123
UEC icon
1833
Uranium Energy
UEC
$4.71B
$27K ﹤0.01%
27,742
-7,000
-20% -$7.09K
ASXC
1834
DELISTED
Asensus Surgical, Inc.
ASXC
$27K ﹤0.01%
3,304
-117
-3% -$1.59K
RIBT
1835
DELISTED
RiceBran Technologies
RIBT
$27K ﹤0.01%
1,102
DHY
1836
Credit Suisse High Yield Credit Fund
DHY
$238M
$26K ﹤0.01%
10,169
LSTA icon
1837
Lisata Therapeutics
LSTA
$15.2M
$26K ﹤0.01%
673
SPY icon
1838
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$26K ﹤0.01%
11,000
+5,000
+83% +$1.48M
CBL
1839
DELISTED
CBL& Associates Properties, Inc.
CBL
$26K ﹤0.01%
20,000
NGD
1840
DELISTED
New Gold Inc
NGD
$24K ﹤0.01%
24,241
+8,266
+52% +$10.1K
VERU icon
1841
Veru
VERU
$36.1M
$24K ﹤0.01%
1,102
MBAI
1842
Check-Cap
MBAI
$8.5M
$23K ﹤0.01%
+620
New +$25.3K
LTBR icon
1843
Lightbridge
LTBR
$246M
$23K ﹤0.01%
2,692
STON
1844
DELISTED
StoneMor Inc.
STON
$23K ﹤0.01%
21,081
HCR
1845
DELISTED
Hi-Crush Inc. Common Stock
HCR
$23K ﹤0.01%
13,000
TTD icon
1846
PUT
Trade Desk
TTD
$8.13B
$22K ﹤0.01%
5,000
+1,000
+25% +$23.8K
PG icon
1847
PUT
Procter & Gamble
PG
$343B
$21K ﹤0.01%
10,000
+8,200
+456% +$969K
UNP icon
1848
PUT
Union Pacific
UNP
$182B
$21K ﹤0.01%
9,200
IBRX icon
1849
ImmunityBio
IBRX
$7.44B
$20K ﹤0.01%
16,714
TSLA icon
1850
CALL
Tesla
TSLA
$1.24T
$19K ﹤0.01%
28,500
-61,500
-68% -$963K

Similar funds

Creative Planning's Q3 2019 Portfolio in Review

As of Q3 2019, Creative Planning held 2,179 positions worth $30.7B, up 3.3% from $29.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.01B of net new capital in Q3 2019, opening 164 new positions and adding to 802 existing holdings. Its largest new stake was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.

By sector, the portfolio is most concentrated in Financials at 4.8% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $92.7M trimmed.

  • Creative Planning's largest Q3 2019 buy was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $124M increase.
  • Creative Planning's biggest Q3 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $92.7M.
  • Creative Planning fully exited Total System Services, Inc. in Q3 2019, selling an estimated $49.4M.
  • Creative Planning's ten largest holdings make up 55% of its $30.7B portfolio in Q3 2019.
  • Creative Planning opened 164 new positions and closed 188 in Q3 2019.
  • Creative Planning's portfolio value rose 3.3% quarter-over-quarter to $30.7B.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.